GDNF-induced neurite formation was stimulated by protein kinase inhibitors and suppressed by Ras inhibitors

Neuroscience Letters

Volumn 238, Issue 3, 1997, Pages 115-118

  Hiwasa, Takaki ^a   Kondo, Kazuhiro ^b   Hishiki, Tomoro ^b   Koshizawa, Sohei ^c   Umezawa, Kazuo ^d   Nakagawara, Akira ^b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA CANCER CENTER   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KEIO UNIVERSITY   (Japan)

Author keywords

c Jun; Differentiation; Glial cell line derived neurotrophic factor; Neuroblastoma; Ras

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CONOPHYLLINE; DAMNACANTHAL; ERBSTATIN; GENISTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HERBIMYCIN A; MANUMYCIN; N (2 GUANIDINOETHYL) 5 ISOQUINOLINESULFONAMIDE; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; OKADAIC ACID; OXANOSINE; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RAS PROTEIN; STAUROSPORINE; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; ONCOGENE C JUN; ONCOGENE RAS; PRIORITY JOURNAL;

ENZYME INHIBITORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURITES; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; POLYENES; POLYUNSATURATED ALKAMIDES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS P21(RAS); STAUROSPORINE; TUMOR CELLS, CULTURED;

EID: 0031555338     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00861-6     Document Type: Article

References (29)

1. Akiyama T., Ishida J., Nakagawa S., Ogawa H., Watanabe S., Itou N., Shibata M., Fukumi Y. Genistein, a specific inhibitor of tyrosine-specific protein kinase. J. Biol. Chem. 262:1987;5592-5595.
2. Boe R., Gjertsen B.T., Vintermyr O.K., Houge G., Lanotte M., Doskeland S.O. The protein phosphatase inhibitor okadaic acid induces morphological changes of typical of apoptosis in mammalian cells. Exp. Cell Res. 195:1991;237-246.
3. Cohen P., Holmes C.F.B., Tsukitani Y. Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem. Sci. 15:1990;98-102.
4. Durbec P., Marcos-Gutierrez C.V., Kilkenny C., Grigoriou M., Wartiowaara K., Suvanto P., Smith D., Ponder B., Costantini F., Saarma M., Sariola H., Pachnis V. GDNF signalling through the Ret receptor tyrosine kinase. Nature. 381:1996;789-793.
5. Enomoto H., Ozaki T., Takahashi E., Nomura N., Tabata S., Takahashi H., Ohnuma N., Tanabe M., Iwai J., Yoshida H., Matsunaga T., Sakiyama S. Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus. Oncogene. 9:1994;2785-2791.
6. Hara M., Akasaka K., Akinaga S., Okabe M., Nakano H., Gomez R., Wood D., Uh M., Tamanoi F. Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc. Natl. Acad. Sci. USA. 90:1993;2281-2285.
7. Hidaka H., Inagaki M., Kawamoto S., Sasaki Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry. 23:1984;5036-5041.
8. Hiramatsu T., Imoto M., Koyano T., Umezawa K. Induction of normal phenotypes in ras-transformed cells by damnacanthal from Morinda citriforia. Cancer Lett. 73:1993;161-166.
9. Itoh O., Kuroiwa S., Atsumi S., Umezawa K., Takeuchi T., Hori M. Induction by the guanosine analogue oxanosine of reversion toward the normal phenotype of K-ras-transformed rat kidney cells. Cancer Res. 49:1989;996-1000.
10. Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fang M., Tamir R., Antonio L., Hu Z., Cupples R., Louis J.-C., Hu S., Altrock B.W., Fox G.M. GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell. 85:1996;1113-1124.
11. Lerner E.C., Zhang T.-T., Knowles D.B., Qian Y., Hamilton A.D., Sebti S.M. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines. Oncogene. 15:1997;1283-1288.
12. Lin L.-F.H., Zhang T.J., Collins F., Armes L.G. Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63:1994;758-768.
13. Lin L.-F.H., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
14. Lloyd A., Yancheva N., Wasylyk B. Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature. 352:1991;635-638.
15. Peng J., Bowden G.T., Domann F.E. Activation of AP-1 by okadaic acid in mouse keratinocytes associated with hyperphosphorylation of c-jun. Mol. Carcinogen. 18:1997;37-43.
16. Rodriguez-Viciana P., Warne P., Dhand R., Vanhaesebroeck B., Gout I., Fry M.J., Waterfield M.D., Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature. 370:1994;527-532.
17. Santoro M., Wong W.T., Aroca P., Santos E., Matoskova B., Grieco M., Fusco A., Di Fiore P.P. An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway. Mol. Cell. Biol. 14:1994;663-675.
18. 2+ dependent protein kinase. Biochem. Biophys. Res. Commun. 135:1986;397-402.
19. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., Duhamel L., Charon D., Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:1991;15771-15781.
20. Treanor J.J.S., Goodman L., de Sauvage F., Stone D.M., Poulsen K.T., Beck C.D., Gray C., Armanini M.P., Pollock R.A., Hefti F., Phillips H.S., Goddard A., Moore M.W., Buj-Bello A., Davies A.M., Asai N., Takahashi M., Vandlen R., Henderson C.E., Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature. 382:1996;80-83.
21. Trupp M., Arenas E., Fainzilber M., Nilsson A.-S., Sieber B.-A., Grigoriou M., Kilkenny C., Salazar-Grueso E., Pachnis V., Arumäe U., Sariola H., Saarma M., Ibáñez C.F. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature. 381:1996;785-789.
22. Tsubuki S., Saito Y., Tomioka M., Ito H., Kawashima S. Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J. Biochem. 119:1996;572-576.
23. Tsubuki S., Kawasaki H., Saito Y., Miyashita N., Inomata M., Kawashima S. Purification and characterization of a Z-Leu-Leu-Leu-MCA degrading protease expected to regulate neurite formation: a novel catalytic activity in proteasome. Biochem. Biophys. Res. Commun. 196:1993;1195-1201.
24. Uehara Y., Hori M., Takeuchi T., Umezawa H. Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kidney cells to 'normal morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase. Jpn. J. Cancer Res. 76:1985;672-675.
25. Umezawa K., Ohse T., Yamamoto T., Koyano T., Takahashi Y. Isolation of a new vinca alkaloid from the leave of Ervatamia microphylla as an inhibitor of ras functions. Anticancer Res. 14:1994;2413-2418.
26. Umezawa H., Imoto M., Sawa T., Isshikik K., Matsuda N., Uchida T., Iinuma H., Hamada M., Takeuchi T. Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3. J. Antibiot. (Tokyo). 39:1986;170-173.
27. van Weering D.H.J., Medema J.P., van Puijenbroek A., Burgering B.M.T., Baas P.D., Bos J.L. Ret receptor kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells. Oncogene. 11:1995;2207-2214.
28. Yano H., Nakanishi S., Kimura K., Hanai N., Saitoh Y., Fukui Y., Nonomura Y., Matsuda Y. Inhibition of histamine secretion by wortmannin through the blockage of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:1993;25846-25856.
29. 2-terminal kinase isoform and induction of neurite outgrowth in PC-12 cells by staurosporine. J. Biol. Chem. 272:1997;18261-18266.